Your browser doesn't support javascript.
loading
Successful pembrolizumab treatment of microsatellite instability-high intrahepatic cholangiocarcinoma: A case report.
Ikeda, Yuki; Ono, Michihiro; Ohmori, Ginji; Ameda, Saki; Yamada, Michiko; Abe, Tomoyuki; Fujii, Shigeyuki; Fujita, Miri; Maeda, Masahiro.
Affiliation
  • Ikeda Y; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Ono M; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Ohmori G; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Ameda S; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Yamada M; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Abe T; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Fujii S; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
  • Fujita M; Department of Pathology and Clinical Laboratory Steel Memorial Muroran Hospital Muroran Japan.
  • Maeda M; Department of Gastroenterology Steel Memorial Muroran Hospital Muroran Japan.
Clin Case Rep ; 9(4): 2259-2263, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33936676
ABSTRACT
The tumor reduction effect of pembrolizumab is extremely high compared to standard chemotherapy and might show prolonged survival. Therefore, the MSI status should be examined in patients with cholangiocarcinoma.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2021 Document type: Article